Last reviewed · How we verify

NCT06657742

Validity and Reliability of SCIM-SR

Completed Last updated 24 October 2024
What this trial tests

trial testing SCIM-SR in Spinal Cord Injuries in 90 participants. Completed in 16 July 2024.

Timeline
16 October 2023
Primary endpoint
16 June 2024
16 July 2024

Quick facts

Lead sponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date16 October 2023
Primary completion16 June 2024
Estimated completion16 July 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Who can join

Adults 18 to 70, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the validity and reliability of SCIM-SR, patients will fill out SCIM 3 and SR.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other Istanbul Physical Medicine Rehabilitation Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06657742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing